Xiao-Wen Tang (Xiaowen Tang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Blood cancer journal

Bone marrow transplantation

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-Shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study. Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Keyuan Zhang, Xiang Zhang, Yang Xu, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, De-Pei Wu, Ying Wang
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Yanming Zhang, Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone marrow transplantation (2022)
Mengqian Chu, Shuhong Hu, Yifan Shen, Danya Shen, Yuchen Zhan, Yi Fan, Jia Chen, Xiao-Wen Tang, Depei Wu, Yang Xu
Comparison of clinical outcomes between peripheral blood stem cells and peripheral blood stem cells plus bone marrow in myelodysplastic syndrome patients with haploidentical transplantation. Bone marrow transplantation (2022)
Tongyan Meng, Jiaqian Qi, Yuanxin Zhu, Yang Xu, Feng Chen, Shengli Xue, Miao Miao, Su-Ning Chen, Yue Han, Xiao-Wen Tang, Huiying Qiu, Aining Sun, Depei Wu, Ying Wang
Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemia. Hematological oncology 39 (3) (2021)
Changju Qu, Yaohua Song, Jia Yin, Yunju Ma, Liqing Kang, Zheng Li, Haiping Dai, Xiaming Zhu, Lei Yu, Depei Wu, Xiao-Wen Tang
Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations. Bone marrow transplantation 56 (7) (2021)
Xiao-Wen Tang, Benigno C Valdez, Yunju Ma, Qianqian Zhang, Changju Qu, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, Jia Chen, Xiaming Zhu, Zixing Chen, Depei Wu, Borje S Andersson
Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 56 (7) (2021)
Jingsheng Hua, Jian Zhang, Xinyou Zhang, Xiaoxia Wu, Lili Zhou, Xiebing Bao, Yue Han, Miao Miao, Caixia Li, Chengcheng Fu, Suning Chen, Xiao-Wen Tang, De-Pei Wu, Huiying Qiu
Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 56 (5) (2020)